Metabolic-Fit / 100
Sprout Health review
Flat pricing through every dose escalation, named partner pharmacies and a state list it actually publishes — undercut by an open FDA warning letter, an F rating at the BBB, and brand-name pens advertised on its site that you cannot buy.
then $299/mo ongoing
- HSA / FSA-eligible
- Editor-vetted
- No insurance needed
Referral link, walled off from the score
Elena Voss is a mother writing for mothers, not a treating clinician, and holds no medical license. Every clinical figure in this piece is cited inline to its primary source — the trial or the FDA label — so you can open it and check us. This is background reading, not medical advice.
Sprout Health at a glance
- Semaglutide
- $299/mo
- Tirzepatide
- $349/mo
- Coverage
- 44 states (not AL, AR, CA, LA, MS, ND)
- Brand-name
- Compounded only
How we scored Sprout Health
Every factor comes from Sprout Health's own published pricing, disclosures and oversight, and the six combine into the 61/100 Metabolic-Fit Score by the same weighted six-factor framework we apply to every provider — never nudged by whether a provider pays us.
No postpartum or breastfeeding framing — a generic weight program.
Thin on the hormonal picture that drives many mothers' weight.
Oversight and lab support fall short of the top of this roster — the review below says exactly where.
Cost is unpredictable or sits at the premium end.
Support is thin once the prescription ships.
Exit terms are the weak point: lock-in, notice periods, or a cancellation you have to chase.
How we verified this review
- Last verified
- July 2026
- Confidence
- high
- Primary source
- joinsprouthealth.com/start-weightloss
$299 for semaglutide and $349 for tirzepatide are the standing rates, confirmed against the live checkout and the store's own data — worth saying, because the widely repeated $149 is a teaser rather than a price anyone keeps paying. Six states are out. The Better Business Bureau rates Sprout F, with 64 complaints on file and 32 of them unanswered.
What to expect when you sign up
We walked Sprout Health's public signup funnel (July 2026) — a first-hand look at the flow. We don't create accounts, enter medical data, or complete checkout, so this is what any visitor sees, not a patient outcome.
- 1Land on one of many quiz landers — the sitemap carries separate pages per traffic source, including /quiz-weightloss-forbes/ and /quiz-weightloss-webmd/ — each leading with a different teaser price
- 2Brand-name pens are advertised alongside them: Wegovy® at $1,579 on one homepage and $1,799 on the other, Zepbound® at $1,249 and $1,999
- 3Answer goal, sex assigned at birth, age band and state, then height and weight; no price is shown at any quiz step, only a promo-code banner
- 4You are charged BEFORE the medical review — the site states so plainly — and the detailed medical questionnaire comes after purchase
What we noticed
- The advertised brand-name pricing is not purchasable — every call to action resolves to the same compounded-only checkout, and no brand product exists in the catalog
- The headline $99/$149 figures are first-month promotional rates; the program price stated in its own FAQ is $299 and $349
- At least four different first-month promotions run simultaneously across its pages ($99 first month, $150 off with FIRST150, $200 off with WELCOME200, $250 off) — the same product at four different entry prices depending on which lander you arrive on
- Pricing is flat across dose escalations, stated verbatim: the monthly payment 'will never increase … EVEN IF your dosage increases in subsequent months'
- The terms publish an explicit state list — 44 states, excluding Alabama, Arkansas, California, Louisiana, Mississippi and North Dakota — but the intake quiz accepted California without blocking
- Two partner compounding pharmacies are named (Foothills Pharmacy and Promise Pharmacy), as is the clinician network, MD Integrations; no medical director is named anywhere
- The 'Excellent 4.9' rating shown on its landers is a hardcoded image, not a live review widget; its actual Trustpilot score is 3.7 across 122 reviews
Pricing
Prices re-verified
| Medication | Monthly | Plan |
|---|---|---|
| Compounded semaglutide | $99 → $299 | Monthly plan (flat, all doses)$99 the first month with code WELCOME200 (monthly plan only), then $299/mo flat through every dose escalation. |
| Compounded tirzepatide | $149 → $349 | Monthly plan (flat, all doses)$149 the first month with code WELCOME200, then $349/mo flat through every dose escalation. |
| Compounded semaglutide | $205 | 3-month planPer-month rate on the 3-month prepay tier ($615 for a three-month supply, discounted to $465 at times). |
| Compounded tirzepatide | $250 | 3-month planPer-month rate on the 3-month prepay tier ($750 for a three-month supply, discounted to $600 at times). |
| Compounded semaglutide | $169 | 6-month planPer-month rate on the 6-month prepay tier — the lowest figure available, and the longest lock-in. |
| Compounded tirzepatide | $229 | 6-month planPer-month rate on the 6-month prepay tier. |
Swipe the table to see plan details →
Many HSA and FSA plans cover GLP-1 telehealth — check yours. These figures are what Sprout Health's own site disclosed at last review; this market re-prices often, so confirm the current number at the source.
What we like
- Flat pricing through every dose escalation, stated explicitly — the bill does not climb as you titrate up
- Names its two partner compounding pharmacies and its clinician network, which is more disclosure than much of this market offers
- Publishes an explicit 44-state list in its terms rather than leaving coverage vague
- Offers a sublingual option for anyone who wants to avoid injections, and 3- and 6-month tiers that cut the monthly rate
- A staffed support phone line with published weekday hours
The caveats
- Carries an FDA warning letter (MARCS-CMS 715879, issued 9 September 2025) over marketing that described GLP-1 medications as FDA-approved; FDA's index records no response and no close-out
- Rated F by the Better Business Bureau, with 64 complaints on file and 32 of them unanswered
- Advertises Wegovy® and Zepbound® between roughly $1,249 and $1,999, but they are not purchasable — every call to action routes to the same compounded-only checkout
- You are charged before the medical review; the detailed medical questionnaire comes after purchase
- Two contradictory refund policies are live at once — its main site promises staged refunds minus a $50 clinical-review fee, its landing-page domain says all prescription medications are non-refundable
- The $99/$149 headline figures are first-month promotional rates; the program price in its own FAQ is $299/$349, and at least four different intro offers run simultaneously
- Not available in Alabama, Arkansas, California, Louisiana, Mississippi or North Dakota — though the intake quiz accepted California without blocking
- The 'Excellent 4.9' rating on its landers is a hardcoded image; the live Trustpilot score is 3.7
- No medical director is named, no lab work is mentioned anywhere, and there is no postpartum, breastfeeding or PCOS material of any kind
An open FDA letter, and brand pens you cannot actually buy
Sprout Health carries an FDA warning letter — MARCS-CMS 715879, issued 9 September 2025 — over marketing that described GLP-1 medications as FDA-approved. FDA's index records no response and no close-out, which means the file is open rather than resolved.
The site also advertises Wegovy and Zepbound at roughly $1,249 to $1,999. You cannot buy them. Every call to action next to those figures routes to the same compounded checkout. A price attached to a product a customer cannot purchase is advertising rather than pricing, and given the letter is about describing compounded medication as approved medication, the two findings point in the same direction.
The Better Business Bureau rates Sprout Health F, with 64 complaints on file and 32 of them unanswered. We keep it listed and scored on the same rubric as everything else, because a letter discloses rather than disqualifies — but a reader deciding tonight deserves all three of those facts before a price.
What it does well, which is not nothing
Pricing is flat through every dose escalation, stated explicitly — the bill does not climb as you titrate up, which is the trap in a large part of this market. Semaglutide is $299 a month and tirzepatide $349, and those are the standing rates rather than a teaser. The widely repeated $149 is not a price anyone keeps paying.
It names its two partner compounding pharmacies and its clinician network, and it publishes an explicit 44-state list in its terms rather than leaving coverage vague — both more disclosure than much of this market offers. A sublingual option is available for anyone avoiding injections, and three- and six-month tiers cut the monthly figure substantially.
- Semaglutide: $299/mo flat at all doses · $205 on 3 months · $169 on 6
- Tirzepatide: $349/mo flat at all doses · $250 on 3 months · $229 on 6
- Disclosed: two named pharmacies, the clinician network, and an explicit state list
- Not available in: AL, AR, CA, LA, MS, ND
- Advertised but not purchasable: Wegovy and Zepbound
The multi-month tiers are where the price actually lands
The gap between the monthly rate and the six-month tier is large — $299 down to $169 on semaglutide, $349 down to $229 on tirzepatide. That is a bigger discount than most of this roster offers for committing, and it is the shape of the offer: the monthly price is not really the product, the multi-month plan is.
Which puts more weight, not less, on the record above. Committing six months to a company with an open FDA letter and 32 unanswered complaints is a different decision from paying for one month and seeing how it goes, and the pricing is designed to push you toward the first. If you do go ahead, the month-to-month rate is the cautious way in even though it costs more.
Who this suits
Someone who wants flat-through-titration pricing on a compounded program, has read the letter and the BBB record and judged them acceptable, and is buying the compounded product rather than being drawn in by the brand pens on the page. If the brand names are what brought you, they are not available here — our cost and insurance guide covers the routes that do sell them.
The bottom line for mothers
Best for: Cost-focused mothers outside its six excluded states who want a price that does not climb as they titrate, and who have read the regulatory record below and are comfortable with it.
Alternatives to Sprout Health
Providers we have a referral relationship with, ordered by their Metabolic-Fit Score — highest first. This module leaves out the provider whose page you are reading, so on CoreAge Rx's own review our #1 pick is the one name you will not find here. These are not the whole roster: see the full ranking for every provider we cover, paid or not.
- Visit CoreAge Rx92
Metabolic-Fit / 100
CoreAge RxOur #1 pickOne flat price, both molecules on a single chart, and a prescriber who reads your history before writing — the most predictable place for a mother to start and, just as important, to pause.
- Visit Gala Health84
Metabolic-Fit / 100
A flat $179 for either molecule with a genuinely gentle microdosing tier — a reasonable, all-doses-included option if you can live with a yearly plan and a pharmacy it doesn't name.
- Visit Enhance MD81
Metabolic-Fit / 100
One of the more oversight-forward compounded programs here — lab work and a live provider visit bundled into every plan, with a gentle microdosing tier — the catch is that the low '$212' headline you'll see quoted is the 12-month prepay rate, not the $249 you'd pay month to month.
Keep comparing Sprout Health
Head-to-head & alternatives
Sprout Health, answered
- Is Sprout Health's $99 price real?
- It is a first-month rate, not a price. The $99 semaglutide and $149 tirzepatide figures apply to the first month only, on the monthly plan, with a promotional code. The standing price is $299 for compounded semaglutide and $349 for compounded tirzepatide. If you want the low number to persist, the 6-month prepay tier gets semaglutide to $169 a month — but that is six months of commitment paid up front. Budget on $299, not $99.
- Can I actually get Wegovy or Zepbound from Sprout Health?
- No, and this is the most important thing on the page. Sprout's site advertises brand-name Wegovy® and Zepbound® at prices between roughly $1,249 and $1,999, but those products are not purchasable: every call to action resolves to the same compounded-only checkout, and no brand product exists in its catalog. If an FDA-approved pen is what you want — and for a mother weighing timing around pregnancy, the on-label product with its own labeling is a reasonable thing to want — you will not get one here.
- Does Sprout Health have a regulatory record I should know about?
- Yes, and we would rather you hear it from us. FDA issued Sprout a warning letter on 9 September 2025 (MARCS-CMS 715879) over marketing that described GLP-1 medications as FDA-approved; FDA's index shows no response and no close-out. It also holds a Better Business Bureau rating of F, with 64 complaints on file and 32 of them unanswered. In fairness, the FDA letter concerns how the product was described in marketing rather than a finding about the medication itself — but an unanswered complaint pattern is a reasonable thing to weigh, and both are why it sits where it does in our ranking.
- Which states does Sprout Health serve?
- 44 of them. Its terms publish the list explicitly, which is more than most of this market does. The exclusions are Alabama, Arkansas, California, Louisiana, Mississippi and North Dakota, and the District of Columbia is not included. Worth checking first if you live in one of those — a published list is only useful if you read it before paying.
Pricing, states and verification reflect Sprout Health's public disclosures at last review; the Metabolic-Fit Score is our editorial judgment per the published methodology. This is background reading, not medical advice — GLP-1 medications are not established as safe in pregnancy or breastfeeding. See our medical disclaimer and how we're funded.